Anti-GPC3 Neutralizing Antibody (V3S-0622-YC4527) (CAT#: V3S-0622-YC4527)

Send Inquiry
  • fig1
    Figure 1 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in WB
  • fig1
    Figure 2 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in DB
  • fig1
    Figure 3 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with GPC3. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; DB; FuncS; IF; Neut; ELISA; FC; IP; ICC
Application Notes The antibody is recommended for detection of GPC3 by FuncS, IF, Neut, ELISA, FC, IP, ICC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target GPC3
Alternative Name SGB; DGSX; MXR7; SDYS; SGBS; OCI-5; SGBS1; GTR2-2
Gene ID 2719
UniProt P51654
Research Area Stem Cell; Signal Pathway

Tested Data

WB

Figure 1 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in WB

Western blot analysis of V3S-0622-YC4527 was performed by loading Human GPC3 Protein (His Tag) in reduced condition Lane 1 and Lane 2 (20 ng and 50 ng) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0622-YC4527 (2 μg/mL) and HRP-conjugated goat anti-human IgG as a secondary antibody (1: 6000). Chemiluminescent detection was performed.

Figure 1 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in WB

DB

Figure 2 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in DB

Dot Blot analysis of V3S-0622-YC4527 was performed by coating with Human GPC3 Protein (His Tag).

V3S-0622-YC4527 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-human IgG as a secondary antibody (1: 6000)

Figure 2 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in DB

ELISA

Figure 3 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in ELISA

ELISA analysis of V3S-0622-YC4527 was performed by coating with Human GPC3 Protein (His Tag). Then blocked with BSA and incubated with V3S-0622-YC4527. The HRP-conjugated goat anti-human IgG as a secondary antibody (1: 5000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-GPC3 Monoclonal Antibody (V3S-0622-YC4527) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry